Artificial intelligence and big data facilitated targeted drug discovery
Authors:
Open Access
- 7 November 2019
- journal article
- review article
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 4 (4) , 206-213
Abstract
Different kinds of biological databases publicly available nowadays provide us a goldmine of multidiscipline big data. The Cancer Genome Atlas is a cancer database including detailed information of many patients with cancer. DrugBank is a database including detailed information of approved, investigational and withdrawn drugs, as well as other nutraceutical and metabolite structures. PubChem is a chemical compound database including all commercially available compounds as well as other synthesisable compounds. Protein Data Bank is a crystal structure database including X-ray, cryo-EM and nuclear magnetic resonance protein three-dimensional structures as well as their ligands. On the other hand, artificial intelligence (AI) is playing an important role in the drug discovery progress. The integration of such big data and AI is making a great difference in the discovery of novel targeted drug. In this review, we focus on the currently available advanced methods for the discovery of highly effective lead compounds with great absorption, distribution, metabolism, excretion and toxicity properties.Keywords
Funding Information
- National Natural Science Foundation of China (2018ZX09735001-004, 81872892)
- “Double First-Class” University project (CPU2018GY20, CPU2018GY38)
This publication has 48 references indexed in Scilit:
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- ZINC: A Free Tool to Discover Chemistry for BiologyJournal of Chemical Information and Modeling, 2012
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- A roadmap to generate renewable protein binders to the human proteomeNature Methods, 2011
- A new protein binding pocket similarity measure based on comparison of clouds of atoms in 3D: application to ligand predictionBMC Bioinformatics, 2010
- Drug—target networkNature Biotechnology, 2007
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Initial sequence of the chimpanzee genome and comparison with the human genomeNature, 2005
- Computational approaches for identification of conserved/unique binding pockets in the A chain of ricinBioinformatics, 2005
- ADMET in silico modelling: towards prediction paradise?Nature Reviews Drug Discovery, 2003